Hypothesis and Theory

Accepted on 10 Jan 2025

A Conceptual Model and Practical Guidance for the Development, Administration, and Evaluation of Individualized Therapies

in Regulatory Science

Lucie Perillat
Andrew McFadyen
Patricia Furlong
James Anderson

Frontiers in Medicine

doi 10.3389/fmed.2025.1493832

Policy Brief

Accepted on 10 Jan 2025

Challenges and ongoing initiatives towards better integrated EU scientific advice

in Regulatory Science

Iordanis Gravanis
Michael Berntgen
Spiros Vamvakas
Pierre Demolis
Paolo Foggi

Frontiers in Medicine

doi 10.3389/fmed.2025.1473346

Original Research

Published on 10 Jan 2025

Comparison of good review practices of seven countries participating in the ECOWAS medicines regulatory harmonisation initiative: identifying opportunities for improvement

in Regulatory Science

Mercy Owusu-Asante
Delese Mimi Darko
Seth Seaneke
Aminata Nacoulma
Oula Ibrahim Olivier Traore
Christianah Mojisola Adeyeye
Abayomi Akinyemi
Coulibaly Assane
Clarisse Épse Kaul Meledje Clamoungou
Oumy Kalsoum Ndao

Frontiers in Medicine

doi 10.3389/fmed.2024.1520892

159 views

Perspective

Accepted on 09 Jan 2025

Navigating the Potential and Pitfalls of Large Language Models in Patient-Centered Medication Guidance and Self-Decision Support

in Regulatory Science

Serhat Aydin
Mert Karabacak
Victoria Vlachos
Konstantinos Margetis

Frontiers in Medicine

doi 10.3389/fmed.2025.1527864

Systematic Review

Published on 08 Jan 2025

Artificial intelligence in healthcare: transforming patient safety with intelligent systems—A systematic review

in Regulatory Science

Francesco De Micco
Gianmarco Di Palma
Davide Ferorelli
Anna De Benedictis
Luca Tomassini
Vittoradolfo Tambone
Mariano Cingolani
Roberto Scendoni

Frontiers in Medicine

doi 10.3389/fmed.2024.1522554

1,866 views

Original Research

Published on 07 Jan 2025

Unmet medical needs definition and incentives: stakeholders perspectives on the reform of the EU pharmaceutical legislation

in Regulatory Science

Io Wens
Zilke Claessens
Alice Vanneste
Liese Barbier
Rosanne Janssens
Isabelle Huys

Frontiers in Medicine

doi 10.3389/fmed.2024.1506243

336 views

Perspective

Published on 07 Jan 2025

Gaps in the ethical governance of pharmaceutical clinical trials in Europe

in Regulatory Science

Rosemarie D. L. C. Bernabe
Shereen A. Dawkins-Cox
Christine C. Gispen-de Wied

Frontiers in Medicine

doi 10.3389/fmed.2024.1507021

469 views

Review

Accepted on 26 Dec 2024

Data altruism and the 'consent' question: A study into the 'consent' models used under the GDPR and how the data altruism mechanism can act as a potential solution for the research community in the reuse of health data

in Regulatory Science

Maria Christofidou
Theodoros N Arvanitis
Dipak Kalra
Nathan Lea
Mahsa Shabani
Pascal Coorevits

Frontiers in Medicine

doi 10.3389/fmed.2024.1489925

246 views

Opinion

Published on 19 Dec 2024

Bridging the gap in AI integration: enhancing clinician education and establishing pharmaceutical-level regulation for ethical healthcare

in Regulatory Science

Alessandro Perrella
Francesca F. Bernardi
Massimo Bisogno
Ugo Trama

Frontiers in Medicine

doi 10.3389/fmed.2024.1514741

545 views

Opinion

Published on 18 Dec 2024

Personalized medicine: when the common becomes the rare

in Regulatory Science

Daniel J. O'Connor

Frontiers in Medicine

doi 10.3389/fmed.2024.1523594

415 views

Technology and Code

Published on 18 Dec 2024

Bridging health registry data acquisition and real-time data analytics

in Regulatory Science

Johannes Schmidt
Sita Arjune
Volker Boehm
Franziska Grundmann
Roman-Ulrich Müller
Philipp Antczak

Frontiers in Medicine

doi 10.3389/fmed.2024.1430676

439 views

Original Research

Accepted on 16 Dec 2024

Development of digital therapeutics in Hwa-byung treatment: exploring innovation potential in Korean medicine through practitioner survey

in Regulatory Science

Chan-Young Kwon

Frontiers in Medicine

doi 10.3389/fmed.2024.1512337

Original Research

Accepted on 16 Dec 2024

Effects of the Paediatric Regulation funding on the development of offpatent medicines in children

in Regulatory Science

Lucia Ruggieri
Silvia Torretta
Viviana Giannuzzi
Alessandra Natale
Mariagrazia Felisi
Adriana Ceci
Fedele Bonifazi

Frontiers in Medicine

doi 10.3389/fmed.2024.1473862

Policy and Practice Reviews

Published on 16 Dec 2024

Biobanks and data interoperability in Latin America: engendering high-quality evidence for the global research ecosystem

in Regulatory Science

Erick Valdés
Juan Alberto Lecaros

Frontiers in Medicine

doi 10.3389/fmed.2024.1481891

414 views

Opinion

Published on 04 Dec 2024

Why we need to be careful with LLMs in medicine

in Regulatory Science

Jean-Christophe Bélisle-Pipon

Frontiers in Medicine

doi 10.3389/fmed.2024.1495582

1,102 views

Policy Brief

Published on 02 Dec 2024

Innovation ecosystems in health and care: the Andalusian Reference Site as an example

in Regulatory Science

A. M. Carriazo
F. Alonso-Trujillo
F. J. Vázquez-Granado
I. Túnez
M. L. Del Moral-Leal

Frontiers in Medicine

doi 10.3389/fmed.2024.1482830

392 views

Navigation group

Articles

A Conceptual Model and Practical Guidance for the Development, Administration, and Evaluation of Individualized Therapies

Challenges and ongoing initiatives towards better integrated EU scientific advice

Comparison of good review practices of seven countries participating in the ECOWAS medicines regulatory harmonisation initiative: identifying opportunities for improvement

Navigating the Potential and Pitfalls of Large Language Models in Patient-Centered Medication Guidance and Self-Decision Support

Artificial intelligence in healthcare: transforming patient safety with intelligent systems—A systematic review

Unmet medical needs definition and incentives: stakeholders perspectives on the reform of the EU pharmaceutical legislation

Gaps in the ethical governance of pharmaceutical clinical trials in Europe

Data altruism and the 'consent' question: A study into the 'consent' models used under the GDPR and how the data altruism mechanism can act as a potential solution for the research community in the reuse of health data

Bridging the gap in AI integration: enhancing clinician education and establishing pharmaceutical-level regulation for ethical healthcare

Personalized medicine: when the common becomes the rare

Bridging health registry data acquisition and real-time data analytics

Development of digital therapeutics in Hwa-byung treatment: exploring innovation potential in Korean medicine through practitioner survey

Effects of the Paediatric Regulation funding on the development of offpatent medicines in children

Biobanks and data interoperability in Latin America: engendering high-quality evidence for the global research ecosystem

Why we need to be careful with LLMs in medicine

Innovation ecosystems in health and care: the Andalusian Reference Site as an example